Research programme: viral infection therapeutics - Koronis
Alternative Names: KP-1212; SN 1212Latest Information Update: 04 Nov 2017
At a glance
- Originator Koronis Pharmaceuticals
- Class Nucleosides
- Mechanism of Action Hepatitis B virus replication inhibitors; Hepatitis C virus replication inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C; Respiratory syncytial virus infections
- Discontinued Hepatitis B
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Hepatitis-C in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Respiratory-syncytial-virus-infections in USA
- 05 Jul 2007 Discontinued - Preclinical for Hepatitis B in USA (unspecified route)